Evidence map›Paper›PMID 35098924›Full record

ArticleeLife2022

Subcellular proteomics of dopamine neurons in the mouse brain.

Benjamin D Hobson, Se Joon Choi, Eugene V Mosharov, Rajesh K Soni, David Sulzer, Peter A Sims

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Understanding the molecular diversity of synapses.Nature reviews. Neuroscience · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Benjamin D HobsonDepartment of Systems Biology, Columbia University Irving Medical Center, New York, United States.ORCID 0000-0002-2745-5318
Se Joon ChoiDivision of Molecular Therapeutics, New York State Psychiatric Institute, New York, United States.
Eugene V MosharovDivision of Molecular Therapeutics, New York State Psychiatric Institute, New York, United States.
Rajesh K SoniProteomics Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, United States.ORCID 0000-0002-4556-4358
David SulzerDepartment of Psychiatry, Columbia University Irving Medical Center, New York, United States.ORCID 0000-0001-7632-0439
Peter A SimsDepartment of Systems Biology, Columbia University Irving Medical Center, New York, United States.ORCID 0000-0002-3921-4837
Columbia University Irving Medical Center · USNew York Psychoanalytic Society and Institute · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
The Dopamine Synapse and Associative LearningR01DA007418 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI David Sulzer · 1999 to 2026
$9.4M
Autoimmune Features of Neurodegenerative DisordersR01NS095435 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SETTE, ALESSANDRO, SULZER, DAVID · 2018 to 2022
$4.2M
Chemical Targeting of Sensors and Pharmacological Probes in the BrainR01MH122470 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SAMES, DALIBOR, SULZER, DAVID · 2020 to 2023
$2.3M
Gene Expression Programs in Maturing Dopamine Neurons: Temporal Regulation, Subcellular Localization, and Alteration by AmphetamineF30DA047775 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HOBSON, BENJAMIN · 2019 to 2023
$239k
NCI NIH HHS P30 CA013696NIDA NIH HHS F30 DA047775NIDA NIH HHS R01 DA007418NIMH NIH HHS R01 MH122470NINDS NIH HHS R01 NS095435
6 · The paper itself

Abstract

Dopaminergic neurons modulate neural circuits and behaviors via dopamine (DA) release from expansive, long range axonal projections. The elaborate cytoarchitecture of these neurons is embedded within complex brain tissue, making it difficult to access the neuronal proteome using conventional methods. Here, we demonstrate APEX2 proximity labeling within genetically targeted neurons in the mouse brain, enabling subcellular proteomics with cell-type specificity. By combining APEX2 biotinylation with mass spectrometry, we mapped the somatodendritic and axonal proteomes of midbrain dopaminergic neurons. Our dataset reveals the proteomic architecture underlying proteostasis, axonal metabolism, and neurotransmission in these neurons. We find that most proteins encoded by DA neuron-enriched genes are localized within striatal dopaminergic axons, including ion channels with previously undescribed axonal localization. These proteomic datasets provide a resource for neuronal cell biology, and this approach can be readily adapted for study of other neural cell types.

Indexed as

ProteomicsAnimalsBrainDNA-(Apurinic or Apyrimidinic Site) LyaseDopaminergic NeuronsEndonucleasesFemaleMaleMiceMultifunctional EnzymesSynaptosomesApex2 protein, mouseDNA-(Apurinic or Apyrimidinic Site) LyaseEndonucleasesMultifunctional Enzymesdopamine neuronmouseneuroscienceParkinson's diseaseproteomicsproximity labeling

Identifiers

PMID35098924
PMCPMC8860448
OpenAlexW4210577179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.